DGHO-Annual Meeting 2017 The Brentuximab Vedotin (Adcetris (R)) meets the unmet medical Need for Patients with Hodgkin's Lymphoma

[Anonymous]

ONCOLOGY RESEARCH AND TREATMENT, 2018; 41 (1-2): 73

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索